These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29738003)

  • 1. Prostate cancer in the Arab population. An overview.
    Al-Abdin OZ; Al-Beeshi IZ
    Saudi Med J; 2018 May; 39(5):453-458. PubMed ID: 29738003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer in Saudi Arabia in 2002.
    Mosli HA
    Saudi Med J; 2003 Jun; 24(6):573-81. PubMed ID: 12847583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer in the Arab World: A View From the Inside.
    Hilal L; Shahait M; Mukherji D; Charafeddine M; Farhat Z; Temraz S; Khauli R; Shamseddine A
    Clin Genitourin Cancer; 2015 Dec; 13(6):505-11. PubMed ID: 26149392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yield of prostate cancer screening at a community based clinic in Saudi Arabia.
    Almutairi AA; Edali AM; Khan SA; Aldihan WA; Alkhenizan AH
    Saudi Med J; 2019 Jul; 40(7):681-686. PubMed ID: 31287128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
    Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
    Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological fundamentals of clinically localized prostate cancer].
    Martínez-Salamanca JI; Ballesteros CM; Carballido Rodríguez J
    Arch Esp Urol; 2011 Oct; 64(8):703-10. PubMed ID: 22052753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.
    Kitagawa Y; Namiki M
    Asian J Androl; 2015; 17(3):475-80. PubMed ID: 25578935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of prostate biopsies in a teaching hospital in Western Saudi Arabia.
    Tayib AM; Mosli HA; Al-Ammari AA
    Saudi Med J; 2003 Aug; 24(8):859-62. PubMed ID: 12939672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 10. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Prostate-Specific Antigen and Telomere Length in a Nationally Representative Sample of Men Without History of Prostate Cancer.
    Wulaningsih W; Astuti Y; Matsuguchi T; Anggrandariyanny P; Watkins J;
    Prostate; 2017 Jan; 77(1):22-32. PubMed ID: 27566127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening.
    Merrill RM; Stephenson RA
    J Urol; 2000 Feb; 163(2):503-10. PubMed ID: 10647666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trade-Off between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era.
    Shen X; Kumar P
    J Urol; 2016 May; 195(5):1397-1402. PubMed ID: 26656266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race-specific reference ranges of serum prostate-specific antigen levels in countries with a low incidence of prostate cancer.
    Ku JH
    BJU Int; 2006 Jan; 97(1):69-72. PubMed ID: 16336331
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate-specific antigen screening: pro.
    Loeb S; Catalona WJ
    Curr Opin Urol; 2010 May; 20(3):185-8. PubMed ID: 20224413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of prostate cancer (cohort study)].
    Merabishvili VM; Petrova NG; Atroshchenko AV; Kharitonov MV
    Vopr Onkol; 2014; 60(4):457-63. PubMed ID: 25552064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
    Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quebec prostate cancer mortality dropped in 1996.
    Meyer F; Moore L; Bairati I; Fradet Y
    Cancer Prev Control; 1998 Aug; 2(4):163-6. PubMed ID: 10093628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening program for prostate cancer at a university hospital in eastern Saudi Arabia.
    Taha SA; Kamal BA
    Saudi Med J; 2005 Jul; 26(7):1104-6. PubMed ID: 16047062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
    Colli JL; Amling CL
    Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.